A Study of an Cognitive Behaviour Therapy for Internalised Stigma Intervention for Inpatients With Psychosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02853396|
Recruitment Status : Unknown
Verified August 2016 by Lisa Wood, University of Manchester.
Recruitment status was: Recruiting
First Posted : August 2, 2016
Last Update Posted : August 5, 2016
|Condition or disease||Intervention/treatment||Phase|
|Cognitive Behaviour Therapy for Internalised Stigma Psychoeducation||Other: Cognitive Behaviour Therapy Other: Psychoeducation||Not Applicable|
A single-blind randomised controlled pilot trial will be conducted comparing a Cognitive Behaviour Therapy formulation driven internalised stigma intervention (experimental group) against a psychoeducational control intervention (control group). It will follow recommendations outlined by the Medical Research Council's framework for the development and evaluation of complex interventions. This will allow for the medication of the intervention if necessary in order to examine what type of intervention is best suited to the inpatient environment.
Aim: To examine the efficacy of a formulation driven intervention for internalised stigma in psychosis with acute inpatients. The intervention will be compared to a brief psychoeducational internalised stigma intervention.
Description of therapies:
Experimental Condition The experimental condition will receive a two hour intervention session (across one or two sessions) which will be based on a Cognitive Behaviour therapy formulation. These sessions will be undertaken within a two week period. The sessions will collaboratively assess and create a narrative of the participants' experiences of stigma, and develop a personalised stigma formulation. A stigma-related goal will be identified and a brief intervention will be collaboratively developed to tackle this goal. The intervention formulation and change mechanisms will draw upon strategies for people who experience psychosis. Intervention strategies may include guided discovery, skills development, normalising and belief change strategies, including behavioural experiments targeting stigma-relevant appraisals and negative beliefs about self including public stereotypes of psychosis, and supporting decisions about whether to disclose.
Control Condition The control condition will receive a two hour session receiving psychoeducation and normalising material relating to stigma in psychosis. The aim of the material is normalise experiences of psychosis and stigma. Information includes prevalence rates of psychosis, experiences of stigma and discrimination commonly reported by those who experience psychosis.
Both interventions will be delivered by the same therapist.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||A Pilot of a Brief Cognitive Behaviour Therapy Formulation Focused Intervention for Internalised Stigma With Acute Inpatients That Experience Psychosis|
|Study Start Date :||July 2016|
|Estimated Primary Completion Date :||February 2017|
|Estimated Study Completion Date :||September 2017|
Experimental: Cognitive behavioural therapy
Cognitive behaviour therapy
Other: Cognitive Behaviour Therapy
Active Comparator: Psychoeducation
- Internalised stigma of mental illness scale [ Time Frame: 10 minutes ]
- Process of Recovery Questionnaire [ Time Frame: 5 minutes ]
- Beck Depression Inventory [ Time Frame: 5 minutes ]
- Beck Hopelessness Scale [ Time Frame: 5 mins ]
- Self-Esteem Rating scale [ Time Frame: 5 mins ]
- Attitudes towards mental health scale [ Time Frame: 5 mins ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02853396
|North east london foundation trust||Recruiting|
|Ilford, Essex, United Kingdom, IG3 8XJ|
|Contact: Lisa Wood, DClinPsy firstname.lastname@example.org|